Cite
HARVARD Citation
Minhinnick, A. et al. (2016). A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults. Vaccine. 34 (11), pp. 1412-1421. [Online].